Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-25

Clinical Trial Update: Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)

View source ↗

Summary

This is a clinical trial update for the PRECISED Substudy examining microalbuminuria as a cardiovascular risk factor, with endpoints related to endothelial dysf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Microalbuminuria, Endothelial Dysfunction | Status: UNKNOWN